120
Participants
Start Date
March 12, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
May 31, 2031
Tobevibart
Tobevibart administered by subcutaneous injection
Elebsiran
Elebsiran administered by subcutaneous injection
RECRUITING
Investigative Site, Auckland
RECRUITING
Investigative Site, Chisinau
RECRUITING
Investigative Site, New York
RECRUITING
Investigative Site, New York
RECRUITING
Investigative Site, New York
RECRUITING
Investigative Site, Baltimore
RECRUITING
Investigative Site, Hanover
RECRUITING
Investigative Site, DeLand
RECRUITING
Investigative Site, Rawalpindi
RECRUITING
Investigative Site, Lahore
RECRUITING
Investigative Site, Frankfurt
RECRUITING
Investigative Site, Chicago
RECRUITING
Investigative Site, Heidelberg
RECRUITING
Investigative Site, Karachi
RECRUITING
Investigative Site, Karachi
RECRUITING
Investigative Site, Murray
RECRUITING
Investigative Site, Chandler
RECRUITING
Investigative Site, Los Angeles
RECRUITING
Investigative Site, Redwood City
RECRUITING
Investigative Site, San Francisco
RECRUITING
Investigative Site, Seattle
RECRUITING
Investigative Site, Hillsborough
RECRUITING
Investigative Site, Calgary
RECRUITING
Investigative Site, Montreal
RECRUITING
Investigative Site, Montreal
RECRUITING
Investigative Site, Ottawa
RECRUITING
Investigative Site, Québec
RECRUITING
Investigative Site, Vancouver
RECRUITING
Investigative Site, Tbilisi
RECRUITING
Investigative Site, Tbilisi
RECRUITING
Investigative Site, Tbilisi
RECRUITING
Investigative Site, Bucharest
RECRUITING
Investigative Site, Bucharest
RECRUITING
Investigative Site, Bucharest
RECRUITING
Investigative Site, Kyiv
RECRUITING
Investigative Site, London
RECRUITING
Investigative Site, London
RECRUITING
Investigative Site, Manchester
RECRUITING
Investigative Site, Nottingham
Vir Biotechnology, Inc.
INDUSTRY